ENTEROBIOTIX

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in the human gut, enabling physicians to prevent and treat debilitating infections and diseases.
ENTEROBIOTIX
Industry:
Biotechnology Clinical Trials Health Care Life Science
Founded:
2017-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.enterobiotix.com
Total Employee:
1+
Status:
Active
Total Funding:
18 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail
Current Advisors List
Board_member
2019-12-01
Current Employees Featured
Andrew Coleman Director @ EnteroBiotix
Director
2017-01-01
James McIlroy CEO @ EnteroBiotix
CEO
2017-03-01
Colin Bennett Non Executive Chairman @ EnteroBiotix
Non Executive Chairman
2017-03-01
Founder
Investors List
Kineticos Ventures
Kineticos Ventures investment in Series A - EnteroBiotix
Scottish Enterprise
Scottish Enterprise investment in Series A - EnteroBiotix
Thairm Bio
Thairm Bio investment in Series A - EnteroBiotix
SIS Ventures
SIS Ventures investment in Series A - EnteroBiotix
Bank Workers Charity
Bank Workers Charity investment in Seed Round - EnteroBiotix
University of Aberdeen
University of Aberdeen investment in Seed Round - EnteroBiotix
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - EnteroBiotix
Equity Gap
Equity Gap investment in Seed Round - EnteroBiotix
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - EnteroBiotix
Equity Gap
Equity Gap investment in Seed Round - EnteroBiotix
Official Site Inspections
http://www.enterobiotix.com Semrush global rank: 1.54 M Semrush visits lastest month: 16.97 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "EnteroBiotix"
EnteroBiotix - Crunchbase Company Profile & Funding
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing …See details»
EnteroBiotix - LinkedIn
EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to ...See details»
Life at EnteroBiotix — EnteroBiotix
If you think you would be a good fit for our team then please email your CV and covering letter to careers@enterobiotix.com. Find out more about our donor programme. Visit Number2.org . …See details»
EnteroBiotix 2025 Company Profile: Valuation, Funding ... - PitchBook
EnteroBiotix General Information Description. Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. The company focuses on creating …See details»
Enterobiotix - 2025 Company Profile - Tracxn
Apr 7, 2025 Enterobiotix is a series B company based in Edinburgh (United Kingdom), founded in 2017. It operates as a Developer of microbiome-based therapeutics for multiple disease …See details»
EnteroBiotix - VentureRadar
EnteroBiotix was established to unlock the full therapeutic potential of Faecal Microbiota Transplantation (FMT) through three core product portfolios targeted at different diseases. Our …See details»
A leading gut therapeutics company — …
Led by an entrepreneurial and experienced management team, supported by a distinguished Board, we're on a mission to transform the lives of patients through best-in-class gut …See details»
EnteroBiotix Company Profile - Craft
EnteroBiotix is a biopharmaceutical company that develops a microbiome therapeutics platform. It utilizes gut microbiome to develop novel medicinal products that restore health and prevent …See details»
EnteroBiotix - Funding, Financials, Valuation & Investors
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. New. Resources. Advanced Search. ... How much funding has this …See details»
EnteroBiotix | Startup Profile and Investments - Bounce Watch
EnteroBiotix is a leading microbiome therapeutics platform company that is focused on transforming the standard of care for patients battling debilitating diseases and infections …See details»
Microbes Reveal Clues About Extraterrestrial Life
1 day ago Notice of Non-Discrimination: Boston University prohibits discrimination and harassment on the basis of race, color, natural or protective hairstyle, religion, sex or gender, …See details»
About EnteroBiotix - PharmiWeb.jobs
Apr 5, 2024 EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics for patients with serious unmet medical needs. The …See details»
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX …
Glasgow, Scotland – 18 March 2025. EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today …See details»
EnteroBiotix lands $34m to take microbiome therapeutics into …
Apr 5, 2024 Microbiome therapeutics company EnteroBiotix has successfully concluded a $34m funding round to support the advancement of clinical programs targeting multiple chronic …See details»
Pioneering gut health biopharma set to expand
Dr James McIlroy, EnteroBiotix CEO and Simon Comer, Scottish National Investment Bank. Financing round totalling £27m enables business to expand and progress clinical trials …See details»
EnteroBiotix - Overview, News & Similar companies - ZoomInfo
Jul 17, 2023 EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy GLASGOW, United Kingdom, March 28, 2023 (GLOBE …See details»
EnteroBiotix - Contacts, Employees, Board Members, Advisors
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
EnteroBiotix Expands Headcount and Premises to Advance …
Glasgow, Scotland – 27 October 2021 – EnteroBiotix, a biopharmaceutical company developing novel highly-diverse microbial therapeutics that enhance the gut microbiome, today …See details»
EnteroBiotix Announces MHRA License Approval and …
Sep 10, 2018 EnteroBiotix, a leading clinical stage microbiome therapeutics company, has been granted a manufacturers ‘specials’ license from the Medicines and Healthcare Products …See details»
Frontrunner in Microbiome Therapeutics - PharmTech
Mar 3, 2023 11. EnteroBiotix. EnteroBiotix Receives MHRA MIA (IMP) Licensure of State‑of-the-Art GMP Manufacturing Facility for Producing Microbiome Therapeutics. Press Release, 11 …See details»